About CapsoVision
CapsoVision is a commercial-stage medical technology company pioneering advanced imaging and artificial intelligence (AI)-empowered solutions for gastrointestinal (GI) disease detection and screening. The Company’s wire-free capsule endoscopy platform—led by its flagship product, CapsoCam Plus®—features 360° panoramic imaging and onboard video storage. CapsoCam Plus® is designed to visualize the small bowel and detect abnormalities such as obscure GI bleeding and Crohn’s disease. CapsoVision’s unique cloud-based architecture allows physicians to review exams via secure CapsoCloud streaming or direct capsule video download without the need for external hardware. Its server-free architecture enables fast streaming and efficient case review without the need for on-site servers or GPU infrastructure, simplifying deployment across care settings.
The Company has also developed its AI capabilities in-house, with the aim of delivering increased sensitivity for identifying polyps and pre-cancerous lesions, reduced viewing times, and enhanced usability of polyp size measurement. These capabilities leverage a growing cloud-based image repository, creating a differentiated and expanding GI data set to inform algorithm development and clinical insights, while providing the scalable infrastructure necessary to support the Company’s forthcoming AI-assisted reading module.
CapsoVision is currently advancing its next product, CapsoCam Colon, to enable non-invasive visualization of the colon and facilitate the detection and measurement of polyps. With a differentiated wire-free design, cloud-based delivery model, panoramic imaging, and integrated AI capabilities, CapsoVision’s technology platform is positioned to expand into additional GI indications—including esophageal disorders and pancreatic cancer—broadening the impact of data-driven, capsule-based diagnostics across the entire GI tract.